Join us on January 30th for part one of our clinical pharmacology 101 webinar series. Nuventra’s CEO, Geoffrey Banks, PhD, will lead the session titled, “How to Form a Clinical Pharmacology Strategy for Your NDA/BLA.”
Part one of this series will cover clinical pharmacology strategy fundamentals including:
- Approaches to Designing a Clinical Pharmacology Program
- How to Build a Clinical Pharmacology Program
- Common Mistakes/Lessons Learned
- Hypothetical Examples of Clinical Pharmacology Programs
All drug programs must address clinical pharmacology to enable an approvable NDA or BLA. Understanding basic clinical pharmacology strategies such as which investigations you need or don’t need and which investigations to do now versus later is important for your program’s overall strategy. Join us to learn more about clinical pharmacology strategy for your NDA or BLA.
Meet the Presenter
Geoffrey Banks, Ph.D.
President & CEO
Geoffrey Banks, Ph.D., founded Nuventra in 2008 and has led the company as both its CEO and as a principal consultant. He has over 18 years of extensive experience in large pharma, biotechnology, and specialty pharma and an established track record of clinical, regulatory, and entrepreneurial success within the pharmaceutical industry.